SidaGhanaV1, Main, Exploration, bibRecord, 000F00

Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire

Identifieur interne : 000F00 ( Main/Exploration ); précédent : 000E99; suivant : 000F01

Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire

Auteurs : Mireille Kalou [Côte d'Ivoire] ; Madeleine Sassan-Morokro [Côte d'Ivoire] ; Lucien Abouya [Côte d'Ivoire] ; Célestin Bile [Côte d'Ivoire] ; Chantal Maurice [Côte d'Ivoire] ; Mathieu Maran [Côte d'Ivoire] ; Odette Tossou [Côte d'Ivoire] ; Thierry Roels [Côte d'Ivoire, Géorgie (pays)] ; Alan E. Greenberg [Côte d'Ivoire, Géorgie (pays)] ; Stefan Z. Wiktor [Côte d'Ivoire, Géorgie (pays)] ; John N. Nkengasong [Côte d'Ivoire, Géorgie (pays), États-Unis]

Source :

Journal of Medical Virology [ 0146-6615 ] ; 2005-02.

RBID : ISTEX:CD3FFB24039AD242B4E2D78C2D1D7121FC626D65

English descriptors

Abstract

We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for Mycobacterium tuberculosis pulmonary in fection. All patients received a standard regimen of 6 months of rifampicin and isoniazid with first 2 months of pyrazinamid with or without cotrimoxazole. Compared with values at start of treatment, median viral load increased by a median of 0.64 log10 copies/ml after 12 months of follow‐up (P = 0.0002). Median CD4+ T‐cell counts were 393 cells/L at start of treatment and 370 cells/L after 12 months of follow‐up (P = 0.61). Levels of serum activation markers decreased significantly at 12 months of follow‐up of the patients for both patients on standard and cotrimoxazole treatment. Levels of viral load, CD4+ T‐cell counts, and markers of immune activation were not different for patients on standard treatment of tuberculosis compared with those on standard and cotrimoxazole treatment. Levels of serum activation markers decreased significantly at 12 months of follow‐up of the patients for both patients on standard and cotrimoxazole treatment. Because viral load is a predictor of disease progression, its persistent elevated levels in blood of HIV‐infected patients co‐infected with tuberculosis, who successfully complete TB treatment, may account for the high mortality observed in this population. J. Med. Virol. 75:202–208, 2005. © 2004 Wiley‐Liss, Inc.

Url:

https://api.istex.fr/document/CD3FFB24039AD242B4E2D78C2D1D7121FC626D65/fulltext/pdf

DOI: 10.1002/jmv.20257

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000853
to stream Istex, to step Curation: 000853
to stream Istex, to step Checkpoint: 000496
to stream Main, to step Merge: 000F44
to stream Main, to step Curation: 000F00

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire</title>
<author><name sortKey="Kalou, Mireille" sort="Kalou, Mireille" uniqKey="Kalou M" first="Mireille" last="Kalou">Mireille Kalou</name>
</author>
<author><name sortKey="Sassan Orokro, Madeleine" sort="Sassan Orokro, Madeleine" uniqKey="Sassan Orokro M" first="Madeleine" last="Sassan-Morokro">Madeleine Sassan-Morokro</name>
</author>
<author><name sortKey="Abouya, Lucien" sort="Abouya, Lucien" uniqKey="Abouya L" first="Lucien" last="Abouya">Lucien Abouya</name>
</author>
<author><name sortKey="Bile, Celestin" sort="Bile, Celestin" uniqKey="Bile C" first="Célestin" last="Bile">Célestin Bile</name>
</author>
<author><name sortKey="Maurice, Chantal" sort="Maurice, Chantal" uniqKey="Maurice C" first="Chantal" last="Maurice">Chantal Maurice</name>
</author>
<author><name sortKey="Maran, Mathieu" sort="Maran, Mathieu" uniqKey="Maran M" first="Mathieu" last="Maran">Mathieu Maran</name>
</author>
<author><name sortKey="Tossou, Odette" sort="Tossou, Odette" uniqKey="Tossou O" first="Odette" last="Tossou">Odette Tossou</name>
</author>
<author><name sortKey="Roels, Thierry" sort="Roels, Thierry" uniqKey="Roels T" first="Thierry" last="Roels">Thierry Roels</name>
</author>
<author><name sortKey="Greenberg, Alan E" sort="Greenberg, Alan E" uniqKey="Greenberg A" first="Alan E." last="Greenberg">Alan E. Greenberg</name>
</author>
<author><name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z." last="Wiktor">Stefan Z. Wiktor</name>
</author>
<author><name sortKey="Nkengasong, John N" sort="Nkengasong, John N" uniqKey="Nkengasong J" first="John N." last="Nkengasong">John N. Nkengasong</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CD3FFB24039AD242B4E2D78C2D1D7121FC626D65</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/jmv.20257</idno>
<idno type="url">https://api.istex.fr/document/CD3FFB24039AD242B4E2D78C2D1D7121FC626D65/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000853</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000853</idno>
<idno type="wicri:Area/Istex/Curation">000853</idno>
<idno type="wicri:Area/Istex/Checkpoint">000496</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000496</idno>
<idno type="wicri:doubleKey">0146-6615:2005:Kalou M:changes:in:hiv</idno>
<idno type="wicri:Area/Main/Merge">000F44</idno>
<idno type="wicri:Area/Main/Curation">000F00</idno>
<idno type="wicri:Area/Main/Exploration">000F00</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire</title>
<author><name sortKey="Kalou, Mireille" sort="Kalou, Mireille" uniqKey="Kalou M" first="Mireille" last="Kalou">Mireille Kalou</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sassan Orokro, Madeleine" sort="Sassan Orokro, Madeleine" uniqKey="Sassan Orokro M" first="Madeleine" last="Sassan-Morokro">Madeleine Sassan-Morokro</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abouya, Lucien" sort="Abouya, Lucien" uniqKey="Abouya L" first="Lucien" last="Abouya">Lucien Abouya</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bile, Celestin" sort="Bile, Celestin" uniqKey="Bile C" first="Célestin" last="Bile">Célestin Bile</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maurice, Chantal" sort="Maurice, Chantal" uniqKey="Maurice C" first="Chantal" last="Maurice">Chantal Maurice</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maran, Mathieu" sort="Maran, Mathieu" uniqKey="Maran M" first="Mathieu" last="Maran">Mathieu Maran</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tossou, Odette" sort="Tossou, Odette" uniqKey="Tossou O" first="Odette" last="Tossou">Odette Tossou</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Roels, Thierry" sort="Roels, Thierry" uniqKey="Roels T" first="Thierry" last="Roels">Thierry Roels</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Division of HIV/AIDS Prevention, National Center for STD, HIV, and TB Prevention, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Greenberg, Alan E" sort="Greenberg, Alan E" uniqKey="Greenberg A" first="Alan E." last="Greenberg">Alan E. Greenberg</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Division of HIV/AIDS Prevention, National Center for STD, HIV, and TB Prevention, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z." last="Wiktor">Stefan Z. Wiktor</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Division of HIV/AIDS Prevention, National Center for STD, HIV, and TB Prevention, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nkengasong, John N" sort="Nkengasong, John N" uniqKey="Nkengasong J" first="John N." last="Nkengasong">John N. Nkengasong</name>
<affiliation wicri:level="1"><country xml:lang="fr">Côte d'Ivoire</country>
<wicri:regionArea>Projet RETRO‐CI, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Division of HIV/AIDS Prevention, National Center for STD, HIV, and TB Prevention, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Division of AIDS/STD/TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, GA; 1600 Clifton Road (MS A25), Atlanta</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Medical Virology</title>
<title level="j" type="alt">JOURNAL OF MEDICAL VIROLOGY</title>
<idno type="ISSN">0146-6615</idno>
<idno type="eISSN">1096-9071</idno>
<imprint><biblScope unit="vol">75</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="202">202</biblScope>
<biblScope unit="page" to="208">208</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-02">2005-02</date>
</imprint>
<idno type="ISSN">0146-6615</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0146-6615</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abidjan</term>
<term>African patients</term>
<term>Becton dickinson</term>
<term>Blood donors</term>
<term>Ccr5</term>
<term>Cote</term>
<term>Cotrimoxazole</term>
<term>Cotrimoxazole group</term>
<term>Cotrimoxazole treatment</term>
<term>Coulibaly</term>
<term>Disease control</term>
<term>Disease progression</term>
<term>Horizontal lines</term>
<term>Human virus</term>
<term>Human virus type</term>
<term>Immune</term>
<term>Immune activation</term>
<term>Immune activation markers</term>
<term>Marker</term>
<term>Median</term>
<term>Median levels</term>
<term>Median plasma</term>
<term>Mycobacterium tuberculosis</term>
<term>Neopterin</term>
<term>Outlier values</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Plasma samples</term>
<term>Pulmonary tuberculosis</term>
<term>Rank test</term>
<term>Regimen</term>
<term>Standard regimens</term>
<term>Standard treatment</term>
<term>Successful treatment</term>
<term>Treatment regimens</term>
<term>Tuberculosis</term>
<term>Tuberculosis patients</term>
<term>Tuberculosis therapy</term>
<term>Tumor necrosis factor</term>
<term>Viral</term>
<term>Viral load</term>
<term>Virus type</term>
<term>Wilcoxon</term>
<term>Wilcoxon test</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abidjan</term>
<term>African patients</term>
<term>Becton dickinson</term>
<term>Blood donors</term>
<term>Ccr5</term>
<term>Cote</term>
<term>Cotrimoxazole</term>
<term>Cotrimoxazole group</term>
<term>Cotrimoxazole treatment</term>
<term>Coulibaly</term>
<term>Disease control</term>
<term>Disease progression</term>
<term>Horizontal lines</term>
<term>Human virus</term>
<term>Human virus type</term>
<term>Immune</term>
<term>Immune activation</term>
<term>Immune activation markers</term>
<term>Marker</term>
<term>Median</term>
<term>Median levels</term>
<term>Median plasma</term>
<term>Mycobacterium tuberculosis</term>
<term>Neopterin</term>
<term>Outlier values</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Plasma samples</term>
<term>Pulmonary tuberculosis</term>
<term>Rank test</term>
<term>Regimen</term>
<term>Standard regimens</term>
<term>Standard treatment</term>
<term>Successful treatment</term>
<term>Treatment regimens</term>
<term>Tuberculosis</term>
<term>Tuberculosis patients</term>
<term>Tuberculosis therapy</term>
<term>Tumor necrosis factor</term>
<term>Viral</term>
<term>Viral load</term>
<term>Virus type</term>
<term>Wilcoxon</term>
<term>Wilcoxon test</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for Mycobacterium tuberculosis pulmonary in fection. All patients received a standard regimen of 6 months of rifampicin and isoniazid with first 2 months of pyrazinamid with or without cotrimoxazole. Compared with values at start of treatment, median viral load increased by a median of 0.64 log10 copies/ml after 12 months of follow‐up (P = 0.0002). Median CD4+ T‐cell counts were 393 cells/L at start of treatment and 370 cells/L after 12 months of follow‐up (P = 0.61). Levels of serum activation markers decreased significantly at 12 months of follow‐up of the patients for both patients on standard and cotrimoxazole treatment. Levels of viral load, CD4+ T‐cell counts, and markers of immune activation were not different for patients on standard treatment of tuberculosis compared with those on standard and cotrimoxazole treatment. Levels of serum activation markers decreased significantly at 12 months of follow‐up of the patients for both patients on standard and cotrimoxazole treatment. Because viral load is a predictor of disease progression, its persistent elevated levels in blood of HIV‐infected patients co‐infected with tuberculosis, who successfully complete TB treatment, may account for the high mortality observed in this population. J. Med. Virol. 75:202–208, 2005. © 2004 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations><list><country><li>Côte d'Ivoire</li>
<li>Géorgie (pays)</li>
<li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
</region>
</list>
<tree><country name="Côte d'Ivoire"><noRegion><name sortKey="Kalou, Mireille" sort="Kalou, Mireille" uniqKey="Kalou M" first="Mireille" last="Kalou">Mireille Kalou</name>
</noRegion>
<name sortKey="Abouya, Lucien" sort="Abouya, Lucien" uniqKey="Abouya L" first="Lucien" last="Abouya">Lucien Abouya</name>
<name sortKey="Bile, Celestin" sort="Bile, Celestin" uniqKey="Bile C" first="Célestin" last="Bile">Célestin Bile</name>
<name sortKey="Greenberg, Alan E" sort="Greenberg, Alan E" uniqKey="Greenberg A" first="Alan E." last="Greenberg">Alan E. Greenberg</name>
<name sortKey="Maran, Mathieu" sort="Maran, Mathieu" uniqKey="Maran M" first="Mathieu" last="Maran">Mathieu Maran</name>
<name sortKey="Maurice, Chantal" sort="Maurice, Chantal" uniqKey="Maurice C" first="Chantal" last="Maurice">Chantal Maurice</name>
<name sortKey="Nkengasong, John N" sort="Nkengasong, John N" uniqKey="Nkengasong J" first="John N." last="Nkengasong">John N. Nkengasong</name>
<name sortKey="Roels, Thierry" sort="Roels, Thierry" uniqKey="Roels T" first="Thierry" last="Roels">Thierry Roels</name>
<name sortKey="Sassan Orokro, Madeleine" sort="Sassan Orokro, Madeleine" uniqKey="Sassan Orokro M" first="Madeleine" last="Sassan-Morokro">Madeleine Sassan-Morokro</name>
<name sortKey="Tossou, Odette" sort="Tossou, Odette" uniqKey="Tossou O" first="Odette" last="Tossou">Odette Tossou</name>
<name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z." last="Wiktor">Stefan Z. Wiktor</name>
</country>
<country name="Géorgie (pays)"><noRegion><name sortKey="Roels, Thierry" sort="Roels, Thierry" uniqKey="Roels T" first="Thierry" last="Roels">Thierry Roels</name>
</noRegion>
<name sortKey="Greenberg, Alan E" sort="Greenberg, Alan E" uniqKey="Greenberg A" first="Alan E." last="Greenberg">Alan E. Greenberg</name>
<name sortKey="Nkengasong, John N" sort="Nkengasong, John N" uniqKey="Nkengasong J" first="John N." last="Nkengasong">John N. Nkengasong</name>
<name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z." last="Wiktor">Stefan Z. Wiktor</name>
</country>
<country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Nkengasong, John N" sort="Nkengasong, John N" uniqKey="Nkengasong J" first="John N." last="Nkengasong">John N. Nkengasong</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F00 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F00 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CD3FFB24039AD242B4E2D78C2D1D7121FC626D65
   |texte=   Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire

Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri